Building Blocks

<p>3-Bromoquinolin-8-ol is an antifungal agent that has been shown to have a wide range of activity against fungi, including some strains of the genus Myrothecium. 3-Bromoquinolin-8-ol inhibits the growth of fungi by binding to sterically complementary sites on their surface, forming a complex with the fungal cell membrane that disrupts ionic balance and leads to leakage of intracellular contents. The compound also has toxic effects on plants, which may be due to its inhibition of chlorophyll synthesis or interference with photosynthesis. 3-Bromoquinolin-8-ol is not active against bacteria and therefore is used as an antifungal agent in agriculture.</p>

<p>3-bromoquinolin-8-amine is a chemical compound that belongs to the group of quinolines. It has overlapping functionalities with other compounds and has been shown to have autofluorescent properties. 3-Bromoquinolin-8-amine can be used in assays, such as mass spectrometric analysis and kinetic studies, to determine its concentration response curves. This compound also has potential for use in cheminformatics and transfection experiments, although validation studies are required.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>4-(2-Oxo-2-phenylethoxy)benzaldehyde is an aldehyde that is used as a starting material for the synthesis of other chemical compounds. It is prepared from phenylacetaldehyde and acetone in the presence of a nucleophile such as hydrochloric acid. The mechanism for this reaction is postulated to be similar to that of the nitronate reduction, which involves the addition of a nucleophile to form an intermediate iminium salt. This intermediate then reacts with hydrogen gas, yielding 4-(2-oxo-2-phenylethoxy)benzaldehyde. The reaction can also be catalyzed by ruthenium or palladium complexes.</p>

<p>3,4,5-Trichloropicolinonitrile is a pyridine derivative that has been shown to be a potent inhibitor of the enzyme xanthine oxidase. Xanthine oxidase catalyses the oxidation of hypoxanthine to xanthine and then to uric acid. This reaction is important in the purification of nucleotides and in the production of uric acid as a component of urine. 3,4,5-Trichloropicolinonitrile binds reversibly to xanthine oxidase by means of its hydrazone group. It reacts with nucleophilic groups on the enzyme's surface and inhibits its activity by preventing access to substrates.<br>3,4,5-Trichloropicolinonitrile has been shown to inhibit xanthine oxidase from human erythrocytes and rat liver preparations.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>4,6-Dimethoxypyrimidine-2-carbonitrile (DMP) is a chemical compound that belongs to the class of sulfones. It has been shown to be effective in the treatment of sulfate-reducing bacteria, such as Clostridium and Desulfovibrio. DMP is also used for the chlorination of organic compounds, such as chlorinated phenols and chlorinated benzenes. DMP can be synthesized by reacting 4,6-dimethoxybenzene with carbon disulfide and sodium hydroxide in aqueous solution.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Methoxy-quinoline-3-carbaldehyde (2MQC) is a novel oxadiazole derivative that has been shown to exhibit good in vitro antimicrobial activity against staphylococcus aureus and typhimurium. 2MQC also has inhibitory properties against the enzyme hepg2, which is involved in the production of reactive oxygen species by neutrophils. 2MQC inhibits the growth of bacteria by binding to their DNA and inhibiting protein synthesis. This compound also has anti-diabetic effects, as it increases glucose uptake and reduces blood sugar levels in mice with high blood sugar levels.</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>(5S)-5-(Propan-2-yl)pyrrolidin-2-one is a vinyl compound that is used in the production of polyvinyl acetate. It is produced by transesterification of vinyl acetate and ethylene oxide, followed by hydrolysis of the ester group. The reaction proceeds via an enzymatic process, which is initiated by lipases.br&gt;<br>(5S)-5-(Propan-2-yl)pyrrolidin-2-one can be converted to other compounds through a number of chemical reactions. For example, it can be oxidized to (5S)-5-(propane-2,3-dione)pyrrolidine with hydrogen peroxide or sodium hypochlorite. It also reacts with potassium permanganate to form (5S)-5-(propane-1,3 diol)pyrrolidine and manganese dioxide to form (5S</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>4-[(1H-Benzimidazol-1-yl)methyl]benzoic acid is an ionic compound. The anion has a focus with a radius of 2.6 Å and the cation has a radius of 1.9 Å. It is stable in aqueous solution and reacts with chloride to form the salt 4-[(1H-Benzimidazol-1-yl)methyl]benzoyl chloride, which is colorless, crystalline, and soluble in water. This compound can be used for analyzing ligands that bind to lanthanide ions (e.g., lanthanum). The analyzes of frameworks have been carried out by single crystal x-ray diffraction methods and fluorescence spectroscopy parameters are given in Table 1.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>2-Chloro-5-ethynylthiophene (2CET) is a x-ray crystal structure that exhibits potent adenosine receptor antagonist activity. 2CET binds to the adenosine receptor in a noncompetitive manner and blocks the receptor, preventing the activation of G proteins. The binding of 2CET to the adenosine receptor leads to an increase in adenine nucleotide levels, which may contribute to its antihypertensive properties. 2CET has also been shown to be a potent agonist at A1 and A2A receptors. It was found that 2CET bound with high affinity to both receptors, but only activated A1 receptors. This indicates that 2CET is capable of stimulating cAMP production without activating other G protein coupled receptors such as angiotensin II type 1 or muscarinic acetylcholine receptors.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>2-Chloro-4-methyl-5,6,7,8-tetrahydroquinoline is an organic compound that belongs to the heterocyclic category of x-ray crystallography. It was prepared in a single crystal form using perchlorate as a solvent. The anisotropic nature of 2-Chloro-4-methyl-5,6,7,8-tetrahydroquinoline has been shown through x-ray diffraction and x ray diffraction analysis.</p>

<p>Versatile small molecule scaffold</p>

<p>1-(2-Methoxypyridin-4-yl)ethanone inhibits 5-lipoxygenase, the enzyme that converts arachidonic acid to leukotrienes. It is a non-selective inhibitor of cyclooxygenases (COXs) 1 and 2 which are responsible for the metabolism of arachidonic acid to prostaglandins. COXs are inhibited by aspirin and other nonsteroidal antiinflammatory drugs (NSAIDs). NSAIDs inhibit both COXs and can be classified as selective or nonselective based on their selectivity for COX-1 vs. COX-2. Celecoxib is a selective inhibitor of COX-2.<br>COX enzymes can be classified into two groups based on the range over which they are active: μm range or nm range. The μm range includes COX-1, COX-3, and PTGS2 and these enzymes regulate the</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Aminopyrrolidine dihydrochloride (APDC) is a fluorescent dye that is used as an absorber in nuclear magnetic resonance spectroscopy. It has been shown to bind to the adenosine receptor and may be used to study the effect of this receptor on heart function. APDC has also been shown to inhibit the binding of quinolinium, pyridinium, and benzoate ligands to their respective receptors, which may be due to its linker group. The molecule is unsymmetrical and organic, with two absorbing groups.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

Versatile small molecule scaffold

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Please enquire for more information about (1R,5R)-2-Azabicyclo[3.2.0]heptane hydrochloride including the price, delivery time and more detailed product information at the technical inquiry form on this page</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Semapimod is an orally bioavailable small molecule drug candidate with anti-inflammatory and neuroprotective properties. Semapimod inhibits the activation of macrophages, which are a type of white blood cells that play a key role in inflammation. This drug also inhibits the production of proinflammatory cytokines, such as IL-1β and TNF-α. Semapimod has been shown to prevent the development of encephalomyelitis, which is a disease that causes inflammation in the brain and spinal cord, by preventing demyelination (the loss or damage of the myelin sheath) in mice. It has also been shown to be effective at treating patients with multiple sclerosis who have not responded to other treatments.</p>

<p>This bromoethoxy linker reacts with nucleophiles and is cleavable under reducing conditions. Useful for targeted drug conjugation strategies.</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>

<p>Versatile small molecule scaffold</p>